• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Constant Therapy

Digital Health Corp Acquires Speech Therapy App Constant Therapy

by Jasmine Pennic 05/31/2017 Leave a Comment

Constant Therapy Raises $2M for Customized Brain Rehab Apps

Digital Health Corp, the parent company of Reflexion Health has acquired Constant Therapy, a speech therapy app for people recovering from stroke, traumatic brain injury, or who have aphasia, dementia and other speech-language disorders. Financial details of the acquisition were not disclosed.For Digital Health Corp, the acquisition will enhance the company’s existing offerings in personalized and affordable home-based therapy solutions that accelerate and improve patient recovery from surgical
Read More

Study: Telehealth-based Programs for Stroke Therapy Accelerates Recovery

by Fred Pennic 05/11/2016 Leave a Comment

Constant Therapy Raises $2M for Customized Brain Rehab Apps

Stroke survivors engaged in telehealth-based stroke therapy programs received 5 times more therapy than patients receiving in­-clinic therapy alone, according to an internal study conducted by Constant Therapy, which provides a science­-based, customized brain rehabilitation software program. After analyzing more than 20 million therapy exercises completed by users on its mobile platform, the company found that stroke patients experience greater improvement in both cognitive and speech accuracy
Read More

Constant Therapy Raises $2M for Customized Brain Rehab Apps

by Fred Pennic 03/11/2016 Leave a Comment

Constant Therapy Raises $2M for Customized Brain Rehab Apps

Constant Therapy, a Boston-based innovator of science-based, customized brain rehabilitation apps announced it has raised $2 million in Series A funding led by Golden Seeds. The round included participation from Kapor Capital, Launchpad Venture Group, Pond Capital and Community Health Network of Connecticut. The company plans to utilize the funding to accelerate the  scientific research, data, marketing and development behind its product. Constant Therapy provides victims of brain trauma —
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |